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Abstract With the exponential increase in minimally
invasive fluoroscopically guided interventional radiolog-
ic procedures, concern has increased about the health
effects on staff and patients of radiation exposure from
these procedures. There has been no systematic
epidemiologic investigation to quantify serious disease
risks or mortality. To quantify all-cause, circulatory
system disease and cancer mortality risks in U.S.
radiologic technologists who work with interventional
radiographic procedures, we evaluated mortality risks in
a nationwide cohort of 88,766 U.S. radiologic technol-
ogists (77% female) who completed a self-administered
questionnaire during 1994–1998 and were followed
through 31 December 2003. We obtained information
on work experience, types of procedures (including
fluoroscopically guided interventional procedures), and
protective measures plus medical, family cancer history,
lifestyle, and reproductive information. Cox proportional
hazards regression models were used to compute relative
risks (RRs) with 95% confidence intervals (CIs).
Between completion of the questionnaire and the end
of follow-up, there were 3,581 deaths, including 1,209
from malignancies and 979 from circulatory system
diseases. Compared to radiologic technologists who
never or rarely performed or assisted with fluoroscopi-
cally guided interventional procedures, all-cause mortal-
ity risks were not increased among those working on
such procedures daily. Similarly, there was no increased
risk of mortality resulting from all circulatory system
diseases combined, all cancers combined, or female
breast cancer among technologists who daily performed
or assisted with fluoroscopically guided interventional
procedures. Based on small numbers of deaths (n=151),
there were non-significant excesses (40%–70%) in
mortality from cerebrovascular disease among technol-
ogists ever working with these procedures. The absence
of significantly elevated mortality risks in radiologic
technologists reporting the highest frequency of inter-
ventional radiography procedures must be interpreted
cautiously in light of the small number of deaths during
the relatively short follow-up. The present study cannot
rule out increased risks of cerebrovascular disease,
specific cancers, and diseases with low case-fatality
rates or a long latency period preceding death.
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Although the development [1] and growing use of cardiac
angiography [2] revolutionized diagnostic assessment of
coronary arteriosclerosis, fluoroscopy was limited mostly
to examinations of the gastrointestinal tract and diagnostic
angiography until the 1980s. Since then, fluoroscopy has
been increasingly used to guide complex cardiac and other
vascular procedures. The increasing availability of a high-
level-control fluoroscopy mode (with greatly improved
visualization of detail made possible by boosting the
radiation output from the X-ray tube) and other technologic
advances led to exponential growth of minimally invasive
interventional radiologic procedures during the 1990s.
Dramatic expansion in the types, complexity, time re-
quired, and wide range of specialists performing fluo-
roscopically guided interventional radiologic procedures
(most specialists, excluding radiologists, without appro-
priate training in radiation sciences) occurred concomi-
tantly, with increasing reports of severe skin burns at X-ray
beam entry sites [3, 4]. Advisories by the U.S. Food and
Drug Administration [5–7] about prolonged fluoroscopy
time, skin injuries, and the absence of patient dose infor-
mation spawned clinical reviews of skin injuries [4] and a
large survey measuring patient radiation doses from 21
types of fluoroscopically guided interventional procedures
[8].
The substantial skin doses [8], unclear skin injury
threshold [9], potential for treatments to require multiple
interventional procedures, and preliminary data linking
specific medical conditions or genetic disorders with
increased radiation sensitivity [4, 10, 11] suggest the
critical need to record cumulative radiation dose and skin
dose in patients’ medical records [3]. Although these
medical problems and associated recommendations are
clearly important for patient care, clinicians have focused
exclusively on preventing acute or short-term effects. The
medical literature provides sparse information about organ
doses or late effects associated with fluoroscopically
guided interventional procedures.
Medical radiation workers, the earliest occupational
group exposed to ionizing radiation [12], comprise
approximately half of the radiation workers in the U.S.
and 2.3 million internationally [13]. Early radiologists
experienced elevated risks of leukemia, skin cancer and
other radiation-related malignancies [14–18], but cancer
(except possibly multiple myeloma) was not increased in
radiologists first employed after 1940 [17, 18]. Studies of
radiologic technologists have been inconsistent, with some
[19–21] but not others [22, 23] demonstrating elevated
leukemia risks. Early radiologic technologists had in-
creased risks of basal cell, but not squamous cell,
carcinoma [24], while Chinese X-ray workers experienced
modest skin cancer excesses (histologic types not speci-
fied), primarily at sites of radiation-related chronic derma-
titis [20]. Early, but generally not more recent, U.S. and
Chinese radiologic technologists had significant female
breast cancer excesses [20, 25–28]; breast cancer was not
increased among Danish medical radiation workers [23].
Although radiation-related carcinogenic effects have
been established for decades, reports linking elevated heart
disease risks with occupational radiation exposures of early
radiologists [29] and radiotherapy given to Hodgkin
lymphoma patients [30] first appeared 15–20 years ago.
The early radiologists and Hodgkin lymphoma patients
likely experienced moderate-to-high and high-dose radia-
tion exposures, respectively, but subsequent reports of
increased heart disease and stroke were linked with
substantially lower levels of radiation exposure among
Japanese atomic bomb survivors [31] and U.S. radiologic
technologists who first worked before 1950 [32]. The
occurrence and time trends for cancer and cardiovascular
disease risks in these radiation-exposed populations are
consistent, with notable reduction in the recommended
exposure limits from an annual level of 3 Sv in 1902 to
0.7 Sv in the mid-1920s, 0.3 Sv in 1934, 0.15 Sv in 1949,
0.05 Sv in 1957, and 0.02 Sv as a 5-year average (not to
exceed 0.05 Sv in any single year) in 1990 [33–35].
In our follow-up of a nationwide, predominantly
female cohort of U.S. radiologic technologists, we have
previously described mortality and cancer incidence
r i s k sa c c o r d i n gt oe m p l o y m e n t history, work practices,
and related occupational characteristics among a subset
of 90,305 technologists who completed a baseline self-
administered questionnaire [36]. In the current investi-
gation, 88,766 technologists who completed a second
self-administered questionnaire that addressed interven-
tional radiographic procedures were followed through
2003 to assess mortality risks caused by various
diseases. To our knowledge, this is the first large
epidemiologic study to assess mortality risks in medical
staff working with interventional radiologic procedures.
Materials and methods
Study population and follow-up
The U.S. Radiologic Technologists (USRT) Study is an
ongoing collaboration among investigators from the U.S.
National Cancer Institute, the University of Minnesota, and
the American Registry of Radiologic Technologists
(ARRT). Details of the study population and follow-up
have been reported elsewhere [36, 37]. In brief, 146,022
radiologic technologists were enrolled into the cohort if
they were certified by the ARRT during 1923–1980 for at
least 2 years and resided in the U.S. or its territories.
Subjects were followed through annual recertifications
with the ARRT and linkage with state, national and other
databases.
A baseline or first self-administered survey, carried out
in the mid-1980s, inquired about employment history,
demographic, lifestyle, and other factors. A second survey,
which was conducted during 1994–1998, was completed
by 88,766 radiologic technologists (72% response rate),
and is the subject of this report. The second survey
obtained updated information about: demographic, anthro-
pometric, cigarette smoking, and selected other lifestyle
114factors; work experience, practices (including fluoroscopi-
cally guided interventional procedures), and protective
measures; and reproductive, medical, and family cancer
history. Hereafter, we refer to the second questionnaire as
“the questionnaire.”
Deaths
Deaths were identified through linkage with the Social
Security Administration Death Mortality File and the
National Death Index. Causes of death were obtained from
death certificates or National Death Index Plus. Deaths
were classified using the underlying cause of death coded
according to the International Classification of Diseases
9th or 10th revisions [38]. There were 3,581 deaths from all
causes, including 979 from all circulatory system condi-
tions and 1,209 from all cancers.
Data collection
The questionnaire asked respondents whether they had
worked with specific radiologic procedures and, if so, the
frequency of performing or assisting with the procedure for
each of three time periods: before 1980, during 1980–1989,
and in 1990 or later. Within each time period, the
technologist was asked to identify the frequency of
conducting that procedure by category: never or rarely,
monthly, weekly, or daily.
Most of the technologists were born between 1940 and
1959 (79%) and were, on average, 49.0 years old at
completion of the second questionnaire (Table 1). Close to
95% of the cohort was Caucasian; the average body mass
index (BMI) was 25.7 (25.3 for women and 27.1 for men);
approximately 13% of cohort members were current
smokers (one-third were former smokers and 53% had
never smoked at the time of completing the questionnaire);
and 32% drank alcohol, but less than one drink per week
(22% never drank alcohol).
Statistical analysis
Person-years of follow-up were compiled from the date of
questionnaire completion to the date of death, last known
vital status, or 31 December 2003, whichever occurred
first. Cox proportional hazards regression models were
used to compute relative risks (RRs) with 95% confidence
intervals (CIs) [39], using age as the survival time variable
[40] and stratifying at baseline for 5-year birth cohorts to
control for secular trends. Confidence intervals and
significance tests were based on the asymptotic normal
distribution of the risk estimates. Risks were calculated
according to whether the technologist had worked with
interventional radiography procedures in each of the three
time periods. Compared to technologists who never or
rarely worked with interventional radiography procedures,
risks were calculated for those who reported working with
them monthly, weekly, or daily. All statistical tests were
two-sided, and P-values were calculated for categorical
tests of trend. To account for working with interventional
procedures in more than one time period, the frequency of
performing these procedures in each time period, plus other
covariates (summarized above and included in the legend
of Table 2), were added to a single model for each cause of
death category. Because several previous analyses have
shown elevated cancer mortality and incidence risks and
increased circulatory system disease risks among U.S.
radiologic technologists who first worked prior to 1950 (or
1940), we also added the year first worked to analyses
conducted using the above-described model.
Results
Work history and mortality of the cohort
Among the 88,766 U.S. radiologic technologists (77%
female) who completed the second self-administered
questionnaire, there were 630,118 person-years accumu-
lated for those successfully followed through 31 December
2003. There was an average of 7.1 years between
completion of the second questionnaire and the end of
follow-up. Most of the technologists first worked with
medical radiation procedures in 1960 or later (80%), began
working between ages 18 and 22 (72%), and worked as a
radiologic technologist for 10 or more years (80%; 45%
worked for 20 or more years; Table 1). During follow-up
there were 3,581 deaths, including 1,209 from malignan-
cies (176 caused by breast cancer, results not shown) and
979 from circulatory system diseases (151 caused by
cerebrovascular disease; Table 2).
Mortality risks in technologists performing or assisting
with fluoroscopically guided interventional procedures
The number of technologists who reported ever performing
or assisting with fluoroscopically guided interventional
procedures was 17,107 before 1980 and declined in
subsequent years, though the proportion of technologists
who reported working daily with these procedures rose
from 32% before 1980 to 37% during 1980–1989 and 44%
in 1990 or later.
All-cause mortality was not increased among radiologic
technologists who ever performed or assisted with
fluoroscopically guided interventional procedures com-
pared to those who never performed such procedures
(Table 2). Similarly, there was no evidence of elevated
mortality risks from all circulatory system diseases or all
cancers combined. Likewise, there was no excess of female
breast cancer before 1980 (RR 1.2, 95% CI 0.7–1.9),
during 1980–1989 (RR 0.8, 95% CI 0.4–1.8), or in 1990 or
later (RR 1.0, 95% CI 0.4–2.5). Based on small numbers of
deaths (n=151), there were non-significant increases
(40%–70%) in mortality from cerebrovascular disease in
two of the three time periods among technologists who had
115Table 1 Demographic and selected work history and lifestyle characteristics by gender in U.S. radiologic technologists who completed a
self-administered questionnaire during 1994–1998
Characteristics Females (n=68,312) Males (n=20,454)
Number % Number %
Birth year
<1930 3,950 5.8 2,182 10.7
1930–39 8,678 12.7 3,409 16.7
1940–49 22,278 32.6 7,271 35.6
1950–59 32,735 47.9 7,547 36.9
1960+ 671 1.0 45 0.2
Age at completion of questionnaire
<30 0 – 0 –
30–39 12,502 18.3 1,756 8.6
40–49 32,334 47.3 9,496 46.4
50–59 15,450 22.6 5,222 25.5
60–69 5,641 8.3 2,681 13.1
≥70 2,385 3.5 1,299 6.3
Race
White 65,515 95.9 18,499 90.4
Black 1,789 2.6 917 4.5
Asian/Pacific Islander 476 0.7 559 2.7
American Indian/Alaskan Native 125 0.2 114 0.6
Other 347 0.5 329 1.6
Unknown 60 0.1 36 0.2
BMI
<18.5 1,205 1.8 110 0.5
18.5–24.9 36,898 54.0 6,036 29.5
25.0–29.9 17,864 26.2 9,828 48.1
30.0–34.9 7,164 10.5 3,124 15.3
≥35.0 3,636 5.3 990 4.8
Unknown 1,545 2.3 366 1.8
Cigarette smoking
Never smoked 37,935 55.5 8,893 43.5
Former smoker 21,083 30.9 8,258 40.4
Current smoker 8,794 12.9 3,077 15.0
Unknown if smoked 500 0.7 226 1.1
Alcohol consumption
Never 15,321 22.4 4,569 22.3
<1 per week 23,377 34.2 4,745 23.2
1–6 per week 17,713 25.9 5,745 28.1
7–13 per week 3,427 5.0 1,512 7.4
≥14 per week 2,750 4.0 1,954 9.6
Unknown 5,724 8.4 1,929 9.4
Year first worked with medical radiation procedures
<1940 511 0.8 186 0.9
1940–49 2,399 3.5 1,239 6.1
1950–59 9,671 14.2 3,156 15.4
1960–69 22,758 33.3 5,871 28.7
≥1970 32,505 47.6 9,845 48.1
Unknown 468 0.7 157 0.8
Age first worked
<18 6,921 10.1 1,091 5.3
18–19 34,526 50.5 5,578 27.3
20–22 17,004 24.9 6,646 32.5
116reported ever working with these procedures. Risks were
not significantly increased in technologists who worked
with these procedures on a daily basis compared to those
who never or rarely performed such procedures for any of
the major categories of cause of death (i.e., all-cause,
circulatory system diseases, or total malignancies) or for
deaths caused by cerebrovascular disease or breast cancer.
In addition, there was no evidence of a significant dose-
response according to frequency of performing or assisting
with fluoroscopically guided interventional procedures for
mortality from all causes, all circulatory system diseases
(or the subcategory of cerebrovascular disease) or total
malignancies (or the subcategory of female breast cancer,
data not shown) for any of the three time periods evaluated.
Statistically significant 1.8- and 3.8-fold mortality risks
were observed for circulatory system and cerebrovascular
diseases (based on 21 and 4 deaths, respectively), and a
borderline significant 1.3-fold risk seen for all-cause
mortality in technologists who reported performing inter-
ventional procedures weekly in 1990 or later. The above
results did not change when the analyses were additionally
adjusted for year first worked (data not shown).
Mortality risks in relation to other risk factors
In contrast to the lack of clearly and consistently elevated
risks or radiation-related dose-response for any mortality
outcomes in those working with fluoroscopically guided
interventional procedures, significantly elevated risks were
apparent for several known risk factors for the causes of
death evaluated. Mortality risks were significantly higher
for males than females for all-cause and circulatory system
mortality; risks declined with increasing alcohol consump-
tion for all circulatory system (including cerebrovascular)
disease; and mortality risks from all causes, all circulatory
system diseases, and total malignancies were approxi-
mately threefold higher among current cigarette smokers.
Mortality risks were 50%–80% increased for those who
were underweight (<18.5 BMI) and 30%–90% increased
for those who were obese (≥35.0 BMI) for all causes,
circulatory system diseases, and total malignancies, though
a trend of increasing mortality with increasing BMI was
statistically significant for all causes and circulatory system
diseases but not total malignancies.
Discussion
Compared with technologists who reported never perform-
ing or assisting with fluoroscopically guided interventional
procedures, those who indicated that they had ever worked
with such procedures did not experience increased mortal-
ity from all causes of death, all circulatory system diseases
(or the subcategory of cerebrovascular disease), or all
malignancies combined (or female breast cancer). Evalua-
tion of mortality risks for these major categories or specific
causes of death did not reveal any significant excesses
among technologists who performed or assisted with these
procedures on a daily basis, though statistically signifi-
cantly elevated risks were found for all circulatory system
diseases and cerebrovascular disease among technologists
who worked with interventional procedures weekly in
1990 or later based on small numbers of deaths. There was,
however, no evidence of a pattern of increasing risk with
increasing frequency of working with fluoroscopically
guided interventional procedures for any of the mortality
outcomes for any of the three time periods examined.
To our knowledge, this is the only large epidemiologic
cohort investigation that has assessed the relation between
the use of interventional radiographic procedures and
mortality risks among medical staff performing or assisting
with such procedures. A special feature that distinguishes
our cohort from other populations of medical radiation
workers is the large subpopulation of female medical
radiation workers exposed to protracted, primarily low-
dose ionizing radiation. The large size of the study
population provides the opportunity to make internal
comparisons and, thus, minimize potential biases resulting
from the healthy worker effect. The cohort is also unique in
its nationwide coverage, the nearly complete mortality
follow-up, and the availability of data on other risk factors
that might confound mortality risks from all causes, all
circulatory system diseases, cerebrovascular disease, all
malignancies, and breast cancer. The extensive data
collection on risk factors other than work-related data
enabled us to adjust for potential confounding effects. Our
study also collected data on work history, a wide range of
radiologic procedures, behavioral characteristics, and pro-
tective measures. Another key feature of the study was the
low proportion of missing data.
Characteristics Females (n=68,312) Males (n=20,454)
Number % Number %
23–24 3,623 5.3 2,847 13.9
≥25 5,770 8.5 4,135 20.2
Unknown 468 0.7 157 0.8
Total number of years worked
<10 13,726 20.1 3,417 16.7
10–19 25,149 36.8 6,013 29.4
≥20 28,969 42.4 10,867 53.1
Unknown 468 0.7 157 0.8
Table 1 (continued)
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118The main limitations of our study are the relatively short
follow-up period for the technologists subsequent to
completion of the questionnaire and the absence of
individual lifetime occupational radiation dosimetry data.
Our analysis focused on surrogate measures for performing
or assisting with fluoroscopically guided interventional
procedures based on responses to the self-administered
questionnaire. The subset of questionnaire respondents
might not be representative of all radiologic technologists
in the cohort because respondents had to survive until the
mid-1990s and complete the questionnaire.
The fact that we did not observe clear patterns of excess
mortality risks at this time does not mean that working with
fluoroscopically guided interventional radiographic proce-
dures is safe. Because these procedures came into common
usage only in the early 1980s, the time since first exposure
is relatively short (i.e.,<20 years) for most technologists,
and follow-up in this study was only about 7 years on
average. Furthermore, the U.S. Radiologic Technologists
cohort was still young at the end of follow-up (mean age
was 56 years), ages when mortality is low in general,
especially from circulatory system diseases and malig-
nancies. We will continue to follow the cohort, including
the subset of technologists performing or assisting with
interventional radiography exposures, and we anticipate
that more definitive mortality risk estimates will be
forthcoming as additional follow-up accrues.
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